Dr. Majed Refaai, MD

NPI: 1730383274
Total Payments
$3.7M
2024 Payments
$834,750
Companies
20
Transactions
887
Medicare Patients
2,096
Medicare Billing
$117,547

Payment Breakdown by Category

Consulting$3.5M (95.2%)
Other$67,526 (1.8%)
Research$40,707 (1.1%)
Travel$33,860 (0.9%)
Education$30,129 (0.8%)
Food & Beverage$6,546 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $3.5M 724 95.2%
Unspecified $40,707 4 1.1%
Honoraria $38,316 17 1.0%
Travel and Lodging $33,860 57 0.9%
Education $30,129 3 0.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $29,210 9 0.8%
Food and Beverage $6,546 73 0.2%

Payments by Type

General
$3.7M
883 transactions
Research
$40,707
4 transactions

Top Paying Companies

Company Total Records Latest Year
CSL Behring $2.2M 545 $0 (2024)
CSL Plasma Inc. $1.3M 228 $0 (2024)
Cerus Corporation $43,887 19 $0 (2024)
Instrumentation Laboratory Company $40,707 4 $0 (2017)
Diagnostica Stago, Inc $38,100 21 $0 (2024)
Zimmer Biomet Holdings, Inc. $30,000 1 $0 (2017)
Bayer HealthCare Pharmaceuticals Inc. $12,669 33 $0 (2019)
Haemonetics Corporation $2,721 7 $0 (2024)
Incyte Corporation $1,198 12 $0 (2017)
HemoSonics LLC $860.22 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $834,750 142 CSL Plasma Inc. ($807,450)
2023 $558,482 118 CSL Plasma Inc. ($535,150)
2022 $693,289 133 CSL Behring ($677,238)
2021 $756,779 142 CSL Behring ($748,260)
2020 $315,870 109 CSL Behring ($309,870)
2019 $296,120 100 CSL Behring ($286,915)
2018 $122,723 56 CSL Behring ($114,077)
2017 $129,901 87 CSL Behring ($41,043)

All Payment Transactions

887 individual payment records from CMS Open Payments — Page 1 of 36

Date Company Product Nature Form Amount Type
12/31/2024 Haemonetics Corporation TEG6S HEMOSTASIS SYSTEM (Device) Travel and Lodging Cash or cash equivalent $386.95 General
Category: DEVICES
12/18/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $6,300.00 General
12/18/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $3,850.00 General
12/18/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $3,850.00 General
12/18/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $3,500.00 General
12/11/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $9,800.00 General
12/11/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $6,650.00 General
12/11/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $4,550.00 General
12/11/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $4,550.00 General
12/11/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $4,550.00 General
12/11/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $3,500.00 General
12/04/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $8,400.00 General
12/04/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $3,850.00 General
11/27/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $9,800.00 General
11/27/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $6,650.00 General
11/27/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $6,300.00 General
11/20/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $11,900.00 General
11/20/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $8,050.00 General
11/20/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $6,300.00 General
11/20/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $5,950.00 General
11/20/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $4,900.00 General
11/13/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $9,800.00 General
11/13/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $9,800.00 General
11/06/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $1,750.00 General
10/30/2024 CSL Plasma Inc. Consulting Fee Cash or cash equivalent $6,300.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 255 417 $51,523 $13,890
2022 3 454 822 $78,597 $26,921
2021 4 804 1,291 $119,947 $44,368
2020 4 583 913 $82,097 $32,368
Total Patients
2,096
Total Services
3,443
Medicare Billing
$117,547
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
86077 Blood bank physician services for cross match and/or evaluation and written report Facility 2023 93 200 $27,634 $7,506 27.2%
85390 Coagulation function screening test with interpretation and report Facility 2023 135 190 $20,298 $5,345 26.3%
86079 Blood bank physician services with written report Facility 2023 27 27 $3,591 $1,039 28.9%
85390 Coagulation function screening test with interpretation and report Facility 2022 295 472 $30,680 $13,637 44.5%
86077 Blood bank physician services for cross match and/or evaluation and written report Facility 2022 97 287 $39,538 $10,921 27.6%
86079 Blood bank physician services with written report Facility 2022 62 63 $8,379 $2,362 28.2%
85390 Coagulation function screening test with interpretation and report Facility 2021 488 774 $50,250 $22,624 45.0%
86077 Blood bank physician services for cross match and/or evaluation and written report Facility 2021 114 308 $42,196 $12,216 29.0%
80502 Comprehensive, clinical pathology consultation Facility 2021 85 91 $11,735 $4,913 41.9%
86079 Blood bank physician services with written report Facility 2021 117 118 $15,766 $4,614 29.3%
85390 Coagulation function screening test with interpretation and report Facility 2020 364 582 $37,830 $17,613 46.6%
86077 Blood bank physician services for cross match and/or evaluation and written report Facility 2020 70 178 $24,386 $7,337 30.1%
80502 Comprehensive, clinical pathology consultation Facility 2020 72 76 $9,640 $4,260 44.2%
86079 Blood bank physician services with written report Facility 2020 77 77 $10,241 $3,159 30.8%

About Dr. Majed Refaai, MD

Dr. Majed Refaai, MD is a Clinical Pathology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730383274.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Majed Refaai, MD has received a total of $3.7M in payments from pharmaceutical and medical device companies, with $834,750 received in 2024. These payments were reported across 887 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($3.5M).

As a Medicare-enrolled provider, Refaai has provided services to 2,096 Medicare beneficiaries, totaling 3,443 services with total Medicare billing of $117,547. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Clinical Pathology
  • Location Rochester, NY
  • Active Since 06/11/2007
  • Last Updated 07/06/2023
  • Taxonomy Code 207ZC0006X
  • Entity Type Individual
  • NPI Number 1730383274

Products in Payments

  • Kcentra (Biological) $75,842
  • HemosIL (Device) $40,707
  • INTERCEPT BLOOD SYSTEM FOR CRYOPRECIPITATION (Device) $38,196
  • Rejuvesol Solution (Drug) $30,000
  • Kovaltry (Drug) $8,619
  • DEVICE-TRANSFUSION (Device) $2,903
  • INTERCEPT BLOOD SYSTEM FOR PLATELETS (Device) $2,771
  • TEG (Device) $2,064
  • Jivi (Drug) $1,920
  • Non-Covered $1,869
  • TEG6S HEMOSTASIS SYSTEM (Device) $587.99
  • QUNATRA QPLUS SYSTEM (Device) $463.81
  • QUANTRA QPLUS SYSTEM (Device) $396.41
  • No Related Product (Device) $123.73
  • FERAHEME (Drug) $108.98
  • Thrombate III (Biological) $99.54
  • ZEPATIER (Drug) $96.55
  • MONOFERRIC (Drug) $94.59
  • VONVENDI (Biological) $73.44
  • TEG6s HEMOSTASIS SYSTEM (Device) $69.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Clinical Pathology Doctors in Rochester